Several pieces of evidence indicate that elastase-2 (ELA2; chymotrypsin-like ELA2) is an alternative pathway to the generation of angiotensin II (ANGII). Elastase-2 knockout mice (ELA2KO) exhibit alterations in the arterial blood pressure and heart rate. However, there is no data on the behavioral consequences of ELA2 deletion. In this study, we addressed this question, submitting ELA2KO and wild-type (WT) mice to several models sensitive to anxiety-and depression-like, memory, and repetitive behaviors. Our data indicates a higher incidence of barbering behavior in ELA2KO compared to WT, as well as an anxiogenic phenotype, evaluated in the elevated plus maze (EPM). While a decrease in locomotor activity was observed in ELA2KO in EPM, this feature was not the main source of variation in the other parameters analyzed. The marble-burying test (MBT) indicated increase in repetitive behavior, observed by a higher number of buried marbles. The actimeter test indicated a decrease in total activity and confirmed the increase in repetitive behavior. The spatial memory was tested by repeated exposure to the actimeter in a 24-h interval. Both ELA2KO and WT exhibited decreased activity compared to the first exposure, without any distinction between the genotypes. However, when submitted to the cued fear conditioning, ELA2KO displayed lower levels of freezing behavior in the extinction session when compared to WT, but no difference was observed during the conditioning phase. Increased levels of BDNF were found in the prefrontal cortex but not in the hippocampus of ELA2KO mice compared to WT. Finally, in silico analysis indicates that ELA2 is putatively able to cleave BDNF, and incubation of the purified enzyme with BDNF led to the degradation of the latter. Our data suggested an anxiogenic-and antidepressant-like phenotype of ELA2KO, possibly associated with increased levels of BDNF in the prefrontal cortex.
Introduction
Elastase-2 (ELA2) is a chymotrypsin-like elastase family member 2A, a serine protease, which is described as an alternative pathway to angiotensin II (ANGII) generation. ELA2 is able to cleave ANGI into ANGII, similarly to angiotensinconverting enzyme (ACE)-mediated reaction. However, ELA2 is also able to generate ANGII directly from angiotensinogen [1] .
The amino-terminal sequence of the first ten residues of ELA2 is identical to the rat pancreatic elastase-2 (EC 3.4.21.71), and the enzyme was called ANGII-forming ELA2 of rat mesenteric arterial bed [2] . The complementary DNA (cDNA) sequence for pancreatic-and rat mesenteric arterial bed-ELA2 showed that they were identical [3] . ELA2 is considered the only representative of this family of proteases that is secreted outside the digestive tract and is involved in ANGII C. R. A. F. Diniz and P. C. Casarotto contributed equally to this work.
generation. This enzyme is widely found in several organs such as lung, pancreas, liver, blood vessels (mesenteric and carotid arteries), heart, and kidney of rodents [1, 4, 5] and, at lower levels, in the rat prefrontal cortex [6] ). The importance of this functional alternative pathway for ANGII generation was demonstrated in heart, carotid, and mesenteric arteries from normotensive and spontaneously hypertensive (SHR) rats [7] . Also, ELA2 is a key player in ACE-independent dysregulation of the renin-angiotensin system in myocardial infarction and, possibly, other cardiovascular diseases [8] .
ANGII, acting through its receptors (AGTR1 and AGTR2), can regulate several behavioral responses. For instance, animals lacking AGTR1 receptors display a facilitated extinction of conditioned fear [9] . On the other hand, animals lacking AGTR2 did not show any changes in step-down test, in the case used to evaluate learning behavior [10] , but AGTR2-KOs displayed an anxiogenic phenotype in the elevated plus maze and light-dark box, attenuated by captopril, an inhibitor of ACE [11, 12] . The systemic administration of AGTR1 antagonist losartan exerted biphasic effects in the forced-swimming test, a model predictive of antidepressantlike effect, with lower doses reducing the immobility time [13] . While captopril was effective in the learned helplessness model [14] , its effect on the forced-swimming test was contaminated by changes in locomotion [15] . However, captopril improved the mood of hypertensive patients, comorbidly suffering from depression [14, 16, 17] . Moreover, in animal models of anxiety such as the elevated plus maze, the treatment with captopril or losartan exerted an anxiolytic-like effect [18] . Taken together, these pieces of evidence indicate a complex role for the renin-angiotensin system in the central nervous system. Thus, the aim of the present study is to describe the phenotype of ELA2KO submitted to models sensitive to anxietyand depression-like responses, repetitive behaviors, and spatial and cued memory. Based on the behavioral profile of ELA2KO, we also analyzed the levels of brain-derived neurotrophic factor (BDNF) in the hippocampus and prefrontal cortex, a neurotrophin that plays a crucial role in these two structures regulating anxiogenic and antidepressant-like responses [19, 20] .
Experimental Procedure

Animals
Adult male and female ELA2KO (38 males/27 females) or C57BL6/j (33 males/33 females) mice, used as wild-type controls (WT), from 12 to 16 weeks of age at the beginning of the experiments, were employed. The ELA2KO were developed in the Max Delbrück Center for Molecular Medicine, Berlin, Germany, and the colony expanded in the Department of Physiology, at the University of São Paulo in Ribeirão Preto [21] . The animals were group housed, with free access to food and water, except during experimental sessions. All efforts were made to minimize animal suffering, and the experimental protocols were approved by the local ethics committee at the University of São Paulo in accordance with international guidelines (protocols 058/2012 and 146/2009). Unless otherwise stated, all experiments were conducted in experimentally naive animals, with independent cohorts of male and female mice. However, since no difference was observed between sexes, all behavioral data includes both males and females of each strain.
Identification of ELA2 mRNA Levels in Mouse Brain
As stated above, ELA2 has been described in several tissues in rats and mice. However, to our knowledge, there is no data pointing to a differential expression in the mouse central nervous system hippocampus or prefrontal cortex. The available literature suggests the expression of cela2a gene in rat prefrontal cortex, measured by microarray [6] or transcriptome sequencing of whole brain [22] methods. Thus, samples from the prefrontal cortex and hippocampus of three males of the experimentally naive C57BL6/j mice were dissected as described below, washed with PBS, and homogenized in Qiazol Lysis ReagentTM (Qiagen, USA). The sample was then incubated with chloroform for 3 min at RT. After being centrifuged at 15,200×g for 10 min at 4°C, the aqueous phase was mixed with isopropanol for 10 min at RT and centrifuged at 15,200×g for 10 min at 4°C. The pellet was washed with 75% EtOH two times, air dried, and dissolved in 20 μL MQwater. Concentration and purity of each RNA sample were determined using NanoDrop (Thermo Scientific). Maxima First-Strand cDNA Synthesis Kit for RT-qPCR with dsDNase (no. K1672, Thermo Scientific) was used to synthesize cDNA from 2 μg of total RNA in the samples. Primers were designed at https://eu.idtdna.com/pages/scitools and purchased from Sigma-Aldrich (Germany).
The following primers for mouse cela2a sequence ( N M _ 0 0 7 9 1 9 . 3 ) w e r e u s e d f o r q P C R : f o r w a r d TCAGGACACTGCTGCTATCT; reverse CAACTACC CTGCTCACATCATC.
For bdnf exon-9, the following primers were used: forward G A A G G C T G C A G G G G C ATA G A C A A A ; r e v e r s e TACACAGGAAGTGTCTATCCTTATG.
Finally, for beta-actin (NM_031144), the following primers were used: forward TGTCACCAACTGGG ACGATA, reverse: GGGGTGTTGAAGGTCTCAAA.
The PCR method used applied SYBR-Green probe according to the manufacturer's instructions. Briefly, qPCR Master Mix (Thermo Scientific, no. K0253) was mixed with 5 μl of cDNA and 0.5 μl of each primers in Hard-ShellTM 96-well PCR plate (BioRad). The reaction was conducted in duplicates, using thermal cycler (BioRad CFX96 Real-Time System), with initial denaturation at 95°C for 10 min. Denaturation and amplification were carried out by 45 cycles of 95°C for 15 s, 63°C for 30s, and 72°C for 30s. BNo template control^(NTC) was included to the reaction and melting curve analysis was done. Results were described by cycle threshold (Ct) values.
Barbering Behavior
The animals were scored for the state of the whiskers and fur, according to a scale for the presence of barbered areas [23] , based on Garner and colleagues' [24] study of body map for barbering behavior (BB). Briefly, an experimenter blind to the genotype scored the animals for the presence or absence of hair loss in any of the following areas: snout, eye area, forehead, chest, and neck/back. The presence of barbering in at least one of these areas assigned the analyzed animal to the Bhair/whisker loss^group. A total of 52 ELA2KO (26 females) and 54 WT (27 females) at 12-16 weeks of age from our colony were analyzed. All animals were experimentally naive at the time of the analysis and were used in other studies not addressed in this article, since barbering analysis did not require additional level of manipulation beyond that applied by the daily maintenance.
Forced-Swimming Test
ELA2KO (ten males/five females) and WT (seven males/eight females) experimentally naive mice were submitted to a 6-min session of forced-swimming test (FST), where the immobility time was measured during the last 4 min [25] . The FST was performed in a cylinder glass (29 cm height × 18 cm diameter) filled with 10 cm water column at 25°C. The water was changed between each trial.
Elevated Plus Maze
ELA2KO (ten males/five females) and WT (seven males/eight females) experimentally naive mice were submitted to elevated plus maze (EPM) for 5 min. The percentage of time and entries in the open arm (OAT and OAE, respectively) and the entries in the enclosed arm (EAE) were analyzed by ANY-MAZE software (Stoelting, USA). The apparatus used was wood made with two opposite open arms (30 cm × 6 cm) and two enclosed arms (30 cm × 6 cm × 5 cm), elevated 50 cm above the ground.
Marble-Burying Test
This test was performed in squared cages (28 × 17 × 13 cm) with 5-cm-deep sawdust bedding and 12 dark-green glass marbles evenly distributed. ELA2KO (six males/five females) and WT (six males/six females) experimentally naive mice were submitted to a 15-min session, and the number of buried marbles (more than two thirds) was determined by an experimenter blind to the treatments or genotype [26] .
Actimeter Test
ELA2KO (seven males/six females) and WT (six males/six females) experimentally naive mice were submitted to a 15-min session in the actimeter (Panlab-Harvard Apparatus, Barcelona, Spain). This apparatus consisted in two frames of 32 infrared beams in a transparent square arena to determine the total activity as well as the repetitive/stereotyped movements [27] .
Fear Conditioning
ELA2KO (five males) and WT (seven males) experimentally naive mice were acclimated (2 min) to context A (24.8 cm long × 25 cm wide × 33.5 cm tall; black walls with metal grid floor) and submitted to the conditioning protocol by pairing of five sound stimulus (30 s, 1 Hz, white noise, 80 dB) with unconditioned stimulus (1 s electrical footshock of 0.6 mA). Time trial interval between paired stimuli varied from 20 to 120 s. Unconditioned stimulus ended simultaneously with sound. Extinction protocol was conducted in context B (24.8 × 25 × 30 cm; striped walls and white flat floor) by delivering 21 sound stimuli, and the time between stimuli varied from 20 to 60 s. The box was cleaned before each trial with a solution of 70% alcohol. Data for both conditioning and extinction protocols were taken as the sum of the time spent in freezing throughout each session and expressed as percentage from WT group. Protocols were performed according to [28] . Freezing was considered when the animals were immobile, except for respiratory movements. Experiments were recorded and analyzed by an experienced observer blinded to the genotype.
Sample Collection and Western Blotting Analysis
Experimentally naive animals (five females ELA2KO; five females WT) were deeply anesthetized with 4% chloral hydrate injected intraperitoneally; the brains were removed and dissected on ice. Samples from hippocampus (HPC) and prefrontal cortex (PFC) were homogenized in lysis buffer [137 mM NaCl; 20 mM Tris-HCl; 10% glycerol) containing protease/phosphatase inhibitor cocktail (Sigma-Aldrich, no. P2714 and no. P0044)]. The homogenate was centrifuged (10,000×g) at 4°C for 15 min and the supernatant collected and stored at − 80°C. Thirty micrograms of total protein content in each sample was incubated with sample buffer [2% SDS; 5% 2-mercaptoethanol; 10% glycerol; 0.002% bromophenol blue; 125 mM Tris-HCl, pH = 6.8], separated in acrylamide gel electrophoresis and transferred to a PVDF membrane. Following blockade with 5%BSA in Tris-buffered saline-Tween20 (TBST) (20 mM Tris-HCl; 150 mM NaCl; 0.1% Tween20), the membranes were exposed to the primary antibody against BDNF (Millipore, USA, no. MABN114) or GAPDH (Santa Cruz, USA, no. sc25778) overnight at 4°C or HRP-conjugated streptavidin (1:10,000, Thermo-Fisher, no. 21126) for 2 h at RT. After washing with TBST, the membranes labeled with anti-BDNF or anti-GAPDH were incubated with secondary HRP-conjugated antibodies for 2 h at RT. Following washing, the membranes were incubated with 4-chloronaphtol (4CN, Perkin Elmer, no. NEL300001EA) for color development or ECL. The dried membranes with 4CN were scanned, and the intensity of bands was determined using ImageJ software (NIH, v.1.49). The chemiluminescence from the membranes exposed to ECL was detected by a CCD camera.
ELA2 Activity on BDNF and In Silico and In Vitro Analysis
Initially, we submitted the mature BDNF sequence to PeptideCutter (http://web.expasy.org/peptide_cutter/). However, ELA2 is not one of the currently present options in this server, so we performed the identifications of putative cleavage sites using non-specific chymotrypsin, and later overlapped to the sites with the residues known to be the targets of ELA2-i.e., Leu, Met, and Phe. The cleavage at Leu219 residue in BDNF mature sequence would result in an approximately 4 kDa lighter chain for this neurotrophin. In order to test this possibility, purified recombinant ELA2 expressed in Escherichia coli from mouse sequence (2 μg; Biorbyt, UK; no. orb246730) was incubated with recombinant human BDNF biotinylated in Lys residues (bBDNF, 200 ng, Alomone Labs, Israel, no. B-250B) in 100 μl of TBS buffer at 37°C at 30 or 60 min. As control, a sample of bBDNF was incubated with 2 μg of BSA in 100 μl of TBS for 60 min at the same temperature. The samples were then added to sample buffer and submitted to western blotting for detection of bBDNF by HRP-conjugated streptavidin (as described above).
Statistical Analysis
The incidence of barbering behavior was analyzed by chisquared test. The FST, EPM, marble-burying test (MBT), fear conditioning, actimeter tests, and western blotting data were analyzed by Student's t test or Mann-Whitney's test when necessary. The two-trial test in actimeter was analyzed by two-way ANOVA (with genotype and trial as factors), followed by Fisher's LSD test. p Values below 0.05 were considered statistically significant.
Results
Barbering Behavior
The chi-squared test indicates a difference on the incidence of barbering behavior in ELA2KO (25 out of 52 scored positive for BB) compared to WT (0 out 54 scored positive): χ 2 = 37.62, p < 0.05; examples can be found in Fig. 1d . No difference was observed for the incidence of BB in ELA2KO males (12 out 26) and females (16 out 26): χ 2 = 1.24, nonsignificant.
Forced-Swimming Test
The Mann-Whitney test indicates a significant effect of genotype, with ELA2KO mice showing decreased immobility time (s) [U = 62.00; p = 0.03], as seen in Fig. 1a .
Elevated Plus Maze
As found in Fig. 1b , the Student's t test indicates a significant effect of genotype in all the parameters analyzed in EPM [i.e., OAT: t(28) = 3.61; OAE: t(28) = 2.17; EAE: t(28) = 2.84, p < 0.05 for all]. Since a significant effect was observed in the number of enclosed arm entries (EAE, considered a locomotion parameter), a covariance analysis of OAT and EAE was performed, and the decrease in OAT in these animals was still significant.
Marble-Burying Test
The Student's t test indicates that ELA2KO mice presented an increase in the number of buried marbles [t(21) = 5.52, p < 0.05] (Fig. 1c) .
Actimeter Test
The Student's t test indicates a significant effect of genotype on total activity [t(23) = 7.86, p < 0.05] and percentage of repetitive movements [t(23) = 3.35, p < 0.05], with ELA2KO showing a decrease in these parameters compared to WT (Fig. 2a, b) . The two-way ANOVA of repeated exposure to actimeter indicates a significant effect of time [F(1, 30) = 14.93, p < 0.05] and genotype [F(1, 30) = 69.87, p < 0.05], but no interaction between these factors [F(1, 30) = 0.13, non-significant] in the total activity of ELA2KO vs WT (Fig. 2c) .
Fear Conditioning
The Student's t test indicates a significant difference between the genotype with ELA2KO exhibiting lower levels of freezing in the extinction [t(10) = 2.67, p < 0.05] but not in the Fig. 2 ELA2KO displayed reduced total activity (a) and increased percentage of repetitive movements (b) in the actimeter compared to WT (n = 12-13/ group). c Repeated exposure to the actimeter led to reduced activity in both ELA2KO (red squares) and WT (black circles; n = 13-19/group). d ELA2KO mice exhibited lower levels of freezing during the extinction phase of contextual fear conditioning (n = 5-7/group). ELA2KO exhibited increased levels of BDNF in the prefrontal cortex (e), but not in the hippocampus (f), compared to WT (n = 5/group). *p < 0.05 from WT in the same session; #p < 0.05 from activity in day 1 in the same genotype (Fig. 2d) .
Western Blotting Data
The Student's t test indicates a significant increase in the BNDF levels in the prefrontal cortex [t(8) = 3.28, p < 0.05] but not in the hippocampus [t(8) = 0.02, non-significant] (Fig. 2e, f) . No changes were observed on the levels of GAPDH in any of the structures analyzed.
Identification of ELA2 mRNA Levels in Mouse Brain
Adult prefrontal cortex and the hippocampus display low but detectable levels of cela2a messenger RNA ( 
ELA2 Activity on BDNF and In Silico and In Vitro Analysis
As shown in Fig. 3a , there is a decrease in the detectable levels of mature BDNF (around 17 kDa) following the incubation with ELA2 (30-60 min at 37°C). The cleavage sites predicted by PeptideCutter, overlapped with those predicted for lowaffinity chymotrypsin, are indicated in the Fig. 3b , and the raw data is available in FigShare [29] .
Discussion
This is the first study describing that ELA2KO animals exhibit anxiogenic-and antidepressive-like phenotype, associated with increased levels of BDNF in the prefrontal cortex. These animals, despite no difference in contextual memory or Pavlovian conditioning, do have a more prominent extinction of aversive memories. No difference was observed between males and females in any of the models; thus, both sexes were grouped together.
The behavior profile observed in the first experimental approach, the forced-swimming test, indicates an antidepressantlike phenotype. This test was initially designed by Porsolt and colleagues [30] and exhibits a high sensitivity to antidepressant compounds (for review see [31] ). However, since it heavily relies on the animal's locomotion, drugs able to increase the general activity, such as stimulants, exert a falsepositive effect. Therefore, a crucial control for this test is the evaluation of the animal's locomotor behavior. Our data indicates that ELA2KO exhibited decreased activity, evaluated in the actimeter test, compared to WT. Therefore, ELA2KO antidepressant-like phenotype was not biased by increased locomotor activity. Curiously, the treatment with imipramine, a drug able to decrease the immobility time in FST, decreases the expression of cela2a gene (GenBank V01233; SwissProt: P00774) in the prefrontal cortex 2 h after a single administration of this antidepressant in rats [6] .
ELA2KO also exhibited an anxiogenic phenotype, as observed by the reduced time spent and entries in the open arm of the EPM. This test is based on the innate fear that rodents exhibit to open spaces and have been extensively used to evaluate drugs with putative anxiolytic properties, as well as to the phenotypic characterization of strains and transgenic animals. The analysis of the number of entries in the enclosed arm (EAE) is considered a locomotion parameter in this model (for review of this model see [32] ). Our data showed a decrease in EAE by ELA2KO compared to WT animals. Thus, we performed a covariance analysis of the percent time spent in the open arm using the EAE as the covariate (OAT). The effect of genotype on OAT persisted after this analysis, showing that the decrease in time spent in the open arms did not depend on a decrease in general exploratory activity.
In line with the observations in the EPM, ELA2KO exhibited increased burying behavior and a significant higher incidence of barbering behavior, also suggestive of anxiogenic phenotype. The MBT, similar to EPM, is sensitive to anxiolytics. However, recent studies suggest that it is not a simple measure of anxiety. For instance, the burying behavior observed in MBT is not triggered by a potential threat, as initially interpreted [26] , but it is a consequence of repetitive behavioral programs. As discussed by Thomas and colleagues [33] , the nature of the object is not relevant, and there is no correlation between the burying behavior and the parameters observed in the light-dark transition test, a classical model based on the innate fear of rodents to illuminated spaces. Reinforcing the idea that MBT and EPM address different aspects of anxiety traits, we analyzed the repetitive behavior of ELA2KO mice in another test. As found in Fig. 2 , these animals indeed displayed increased repetitive movements in the actimeter. Therefore, it is plausible to interpret that ELA2KO animals also display pro-compulsive/repetitive behavior.
The next experimental set was designed to evaluate spatial memory; thus, the animals were exposed to the actimeter in two consecutive days. This approach was chosen to minimize the impact of stress and therefore anxiety, as compared for example to Morris' water-maze. The re-exposure to the1 § actimeter environment led to a decrease in the exploratory behavior of both WT and KO animals, as evidenced by the reduction in the total activity. Since the reduced activity exhibited by ELA2KO compared to WT persisted in the second trial and concomitantly reduced compared to the first trial, it is plausible to consider that this parameter was not due to the anxiogenic phenotype of ELA2KO. The lack of interaction between the genotype and the trial sessions reinforces the proposition that ELA2KO spatial memory is not compromised. Then, ELA2KO mice were submitted to the cued fear conditioning protocol, where these animals displayed reduced levels of freezing in the extinction session, but no change in the conditioning. Therefore, ELA2KO mice present complex behavioral phenotype related to anxiety, with increased expression of innate fear/anxiety responses, as observed in the EPM, whereas normal or attenuated conditioned fear/anxiety responses and increased extinction of learned fear. We interpret that such phenotype features are consequence of the changes in BDNF levels observed in the prefrontal cortex, but not in hippocampus of ELA2KO.
BDNF and its receptor are considered to play a crucial role in memory, anxiety, and depressive-like behavior; this system is suggested to be necessary and sufficient to mediate antidepressant-like phenotype and the effect of antidepressant drugs [19, 20, [34] [35] [36] . The present study indicates that ELA2KO animals display an anxiogenicand antidepressive-like phenotype, which matches the described phenotype for mice with increased levels of BDNF [37] . BDNF/TRKB system also plays a core role mediating neuroplastic processes both in hippocampus and cortical areas [19, 38, 39] . In line with our findings, mice lacking one of the copies of bdnf gene (BDNF+/−), with approximately 50% of BDNF brain levels [28] , or mice overexpressing the truncated isoform of TRKB [35] , are more vulnerable to stress, resistant to learning, or less flexible to extinguish aversive memories.
As described in the present study, ELA2KO showed increased levels of BDNF in the prefrontal cortex and facilitated extinction in fear conditioning. Some pieces of evidence indicate that BDNF in the prefrontal cortex is involved in the expression of learned fear, with distinct roles for its subdivisions. Infusion of BDNF into the infralimbic portion of the prefrontal cortex led to a facilitation in cued fear extinction with no effect in the conditioning [40] . Yet, the selective knockout of BDNF in the prelimbic prefrontal cortex [41] also leads to a facilitation in cued fear extinction, without any effects on innate fear responses.
A possible scenario concerns the processing of mature BDNF (mBDNF) by ELA2. It has been described that ELA2 participates in the cleavage of angiotensin I into II [2] . Based on this evidence, we tested if the proteolytic properties of ELA2 could be applied to mBDNF. First, we submitted the mBDNF sequence to PeptideCutter databank of proteases. Since ELA2 is not among the options in this server, we decided to use low-affinity chymotrypsin as a parameter. As expected, several residues in the mBDNF sequence were suitable to be degraded by the chymotrypsin. Then, we overlapped these residues with putative sites for ELA2 activity, i.e., Phe, Leu, and Met residues, as indicated in Fig. 3 . Then, we estimated the changes in mBDNF weight starting from the first C-terminal residue. Acting on the C-terminal Leu residues, ELA2 would lead to a 4-kDa lighter product from mBDNF. Interestingly, we observed a roughly 4 kDa lighter product after incubating biotinylated BDNF with purified ELA2, and the blot intensity for this product increases with longer incubation time.
Taken together, the in silico data provides an interesting model for the interaction between ELA2 and mBDNF, at least partially confirmed by experimental data, which in turn may provide a mechanism for the increased levels of mBDNF in ELA2KO prefrontal cortex. However, it is important to highlight that to this point, we cannot assure that such interaction indeed occur in vivo, or have a role, if any, in BDNF metabolism leading to behavioral consequences. Even the literature regarding the existence of cela2a gene expression in the central nervous system is scarce. Using transcriptome sequencing (RNA-Seq) analysis of nine tissues from five vertebrates, one study described high levels of cela2a expression in the whole rat brain [22] . Nevertheless, this study did not dissect brain regions putatively implicated in behavioral outcome. Therefore, the source of ELA2 cannot be pinned to specific regions or even discard of being from brain blood vessels. In Fig. 3 a Recombinant mouse ELA2 degrades BDNF. Biotinylated BDNF (BDNF, 200 ng) was incubated with purified ELA2 (2 μg; 30 or 60 min at 37°C in TBS buffer). The mixture was resolved by electrophoresis, transferred to PVDF membranes, and developed after incubation with HRP-conjugated streptavidin. As control BDNF (200 ng) + 2 μg of BSA was kept at 37°C for 60 min. b Predicted sites of BDNF cleavage by ELA2, the Leu (blue), Phe (red), or Met (green) residues were overlapped with low-affinity chymotrypsin cleavage sites another study, the levels of cela2a was observed by microarray following treatment with imipramine, in prefrontal cortex of rats [6] but no confirmatory analysis by PCR was performed, as well as no comparison with other regions involved in this drug effect such as the hippocampus. In an attempt to replicate and refine the findings in these two studies, we performed PCR analysis of cela2a gene expression in two regions of adult mouse brain, i.e., the prefrontal cortex and hippocampus, and observed similar levels of expression in both. For comparative reasons, we also assessed the levels of bdnf exon 9 in the same samples. This exon reflects the total levels of bdnf gene expression [42] . We observed approximately 7500 times higher expression of bdnf exon 9 than cela2a in the prefrontal cortex and 8500 times in the hippocampus. However, to this point, it is still unclear for us what the mechanism behind the selective increment of mBDNF protein levels in ELA2KO animals in the prefrontal cortex is.
Beyond the changes in BDNF levels, the behavioral phenotype of ELA2KO can be interpreted based on the role of elastases on protease-activated receptors (PARs), mainly PAR-2 [43] . The function of several G-protein-coupled receptors that can be regulated by proteases has been described [44] . However, specifically to elastases, the literature to such relationship is scarce. Some pieces of evidence point that PAR-2 can be activated by elastases [45, 46] , triggering neurodegenerative effects and increasing neuronal death [47] . The induction of a cellular insult, such as the microinjection of kainate into the hippocampus, leads to infiltration of polymorphonuclear leukocytes (PMNs) in this structure, and the coculture of neuronal cells with PMNs induces a strong neurotoxic effect, which is attenuated by protease inhibitors [48] . Yet, this later effect of protease inhibitors only minimally involved serine proteases. As these authors observed, the use of a serine protease inhibitor was not able to counteract the effect of PMNs and kainate insult together in hippocampal cultures but increased neuronal viability when compared to kainate effect alone.
Interestingly, depressed patients exhibited higher levels of PMN elastase in the serum compared to healthy controls, and such levels are decreased following the treatment with imipramine or moclobemide [49] . However, there is so far no evidence of such a relationship between depression and ELA2. Thus, another curious scenario embeds the Bleakingô f serum elastases, putatively including ELA2, to central nervous system following an insult such as hyperactivity of glutamatergic neurotransmission and/or stress.
The increase in glutamate release seems to be a key factor in the responses during and after stressful events [50, 51] . Moreover, the blockade of NMDA receptors exerts antidepressant-like effect in rats submitted to the forcedswimming test [52] or the learned helplessness paradigm [53] . Therefore, it is possible to consider that the lack of ELA2 could partially prevent the activation of PAR-2, attenuating the deleterious effects of exacerbated glutamatergic neurotransmission.
As pointed before, the main limitation in the present study is that the mechanism of how ELA2 contributes to an anxiogenic-and antidepressant-like phenotype is not clear. Further studies will be necessary not only to dissect the systems associated to ELA2KO phenotype, but also to understand the interaction between this protease and neuronal development that might underlie such phenotype.
